These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36174116)

  • 21. A novel protein glycan biomarker and future cardiovascular disease events.
    Akinkuolie AO; Buring JE; Ridker PM; Mora S
    J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study.
    Tian C; Mahara G; Zhang H; Tan X
    BMJ Open; 2022 Jul; 12(7):e058922. PubMed ID: 35868824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary protein intake and incidence of type 2 diabetes in Europe: the EPIC-InterAct Case-Cohort Study.
    van Nielen M; Feskens EJ; Mensink M; Sluijs I; Molina E; Amiano P; Ardanaz E; Balkau B; Beulens JW; Boeing H; Clavel-Chapelon F; Fagherazzi G; Franks PW; Halkjaer J; Huerta JM; Katzke V; Key TJ; Khaw KT; Krogh V; Kühn T; Menéndez VV; Nilsson P; Overvad K; Palli D; Panico S; Rolandsson O; Romieu I; Sacerdote C; Sánchez MJ; Schulze MB; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; Würtz AM; Zamora-Ros R; Langenberg C; Sharp SJ; Forouhi NG; Riboli E; Wareham NJ;
    Diabetes Care; 2014 Jul; 37(7):1854-62. PubMed ID: 24722499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.
    Forouhi NG; Koulman A; Sharp SJ; Imamura F; Kröger J; Schulze MB; Crowe FL; Huerta JM; Guevara M; Beulens JW; van Woudenbergh GJ; Wang L; Summerhill K; Griffin JL; Feskens EJ; Amiano P; Boeing H; Clavel-Chapelon F; Dartois L; Fagherazzi G; Franks PW; Gonzalez C; Jakobsen MU; Kaaks R; Key TJ; Khaw KT; Kühn T; Mattiello A; Nilsson PM; Overvad K; Pala V; Palli D; Quirós JR; Rolandsson O; Roswall N; Sacerdote C; Sánchez MJ; Slimani N; Spijkerman AM; Tjonneland A; Tormo MJ; Tumino R; van der A DL; van der Schouw YT; Langenberg C; Riboli E; Wareham NJ
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):810-8. PubMed ID: 25107467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohorts.
    Mühlenbruch K; Menzel J; Dörr M; Ittermann T; Meisinger C; Peters A; Kluttig A; Medenwald D; Bergmann M; Boeing H; Schulze MB; Weikert C
    Sci Rep; 2020 Sep; 10(1):15373. PubMed ID: 32958955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study.
    Lu X; Wang L; Wang M; Li Y; Zhao Q; Shi Y; Zhang Y; Wang Y; Wang W; Ji L; Hou H; Li D
    Front Immunol; 2023; 14():1257906. PubMed ID: 37809087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association of Serum Immunoglobulins with Risk of Cardiovascular Disease and Mortality: the Rotterdam Study.
    Khan SR; Dalm VASH; Ikram MK; Peeters RP; van Hagen PM; Kavousi M; Chaker L
    J Clin Immunol; 2023 May; 43(4):769-779. PubMed ID: 36723716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic stroke is associated with the pro-inflammatory potential of N-glycosylated immunoglobulin G.
    Liu D; Zhao Z; Wang A; Ge S; Wang H; Zhang X; Sun Q; Cao W; Sun M; Wu L; Song M; Zhou Y; Wang W; Wang Y
    J Neuroinflammation; 2018 Apr; 15(1):123. PubMed ID: 29699572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia.
    Liu D; Chu X; Wang H; Dong J; Ge SQ; Zhao ZY; Peng HL; Sun M; Wu LJ; Song MS; Guo XH; Meng Q; Wang YX; Lauc G; Wang W
    J Transl Med; 2018 Aug; 16(1):235. PubMed ID: 30157878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation.
    Eichelmann F; Sellem L; Wittenbecher C; Jäger S; Kuxhaus O; Prada M; Cuadrat R; Jackson KG; Lovegrove JA; Schulze MB
    Circulation; 2022 Jul; 146(1):21-35. PubMed ID: 35422138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
    Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
    Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
    Dalmeijer GW; van der Schouw YT; Magdeleyns EJ; Vermeer C; Verschuren WM; Boer JM; Beulens JW
    Diabetes Care; 2013 Nov; 36(11):3766-71. PubMed ID: 23877986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study.
    Iqbal K; Schwingshackl L; Floegel A; Schwedhelm C; Stelmach-Mardas M; Wittenbecher C; Galbete C; Knüppel S; Schulze MB; Boeing H
    Eur J Nutr; 2019 Jun; 58(4):1673-1686. PubMed ID: 29761319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult population.
    Schiborn C; Kühn T; Mühlenbruch K; Kuxhaus O; Weikert C; Fritsche A; Kaaks R; Schulze MB
    Sci Rep; 2021 Oct; 11(1):19609. PubMed ID: 34608230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replacement of Saturated Fatty Acids from Meat by Dairy Sources in Relation to Incident Cardiovascular Disease: The European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study.
    Vogtschmidt YD; Soedamah-Muthu SS; Imamura F; Givens DI; Lovegrove JA
    Am J Clin Nutr; 2024 Jun; 119(6):1495-1503. PubMed ID: 38608753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications.
    Birukov A; Eichelmann F; Kuxhaus O; Polemiti E; Fritsche A; Wirth J; Boeing H; Weikert C; Schulze MB
    Diabetes Care; 2020 Dec; 43(12):2930-2937. PubMed ID: 32816995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma.
    Pan H; Wu Z; Zhang H; Zhang J; Liu Y; Li Z; Feng W; Wang G; Liu Y; Zhao D; Zhang Z; Liu Y; Zhang Z; Liu X; Tao L; Luo Y; Wang X; Yang X; Zhang F; Li X; Guo X
    Front Immunol; 2023; 14():981861. PubMed ID: 36999031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to workplace sexual harassment and risk of cardiometabolic disease: a prospective cohort study of 88 904 Swedish men and women.
    Kc P; Madsen IEH; Rugulies R; Xu T; Westerlund H; Nyberg A; Kivimäki M; Hanson LLM
    Eur J Prev Cardiol; 2024 Sep; 31(13):1633-1642. PubMed ID: 38875457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.